Shenzhen ABROBOT Medical Robot Co., Ltd. said it has raised tens of millions of yuan in a Series A+ funding round led by Puhe Capital, with Longgang Financial Holdings participating.
Founded in June 2020 by Professor Guo Shuxiang, a foreign member of the Engineering Academy of Japan and an IEEE Fellow, and his team, ABROBOT focuses on the development and commercialization of vascular interventional surgical robots.
Its products cover neurological, coronary, peripheral and oncological interventions. The company’s first-generation PANVIS-A cerebrovascular interventional surgical assistance system received a Class III registration certificate from China’s National Medical Products Administration in August 2024.
AGIBOT
Figure AI
UBTECH